{"id":9689,"date":"2021-05-28T09:53:25","date_gmt":"2021-05-28T09:53:25","guid":{"rendered":"https:\/\/i3tk.org\/demo2\/?p=9689"},"modified":"2021-06-21T04:22:44","modified_gmt":"2021-06-21T04:22:44","slug":"india-pfizer-at-impasse-over-vaccine-indemnity-demand-report","status":"publish","type":"post","link":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/","title":{"rendered":"India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report"},"content":{"rendered":"\n<ul class=\"wp-block-list\"><li><\/li><\/ul>\n\n\n\n<p><strong>New Delhi\/New York:&nbsp;<\/strong>Pfizer and New Delhi are at loggerheads over a demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world\u2019s biggest markets, two sources told Reuters.&nbsp;India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects, which is a condition Pfizer has obtained in many countries where its shots have already been widely rolled out, including Britain and the United States.<\/p>\n\n\n\n<p>\u201cThe whole problem with Pfizer is the indemnity bond. Why should we sign it?\u201d a government source with direct knowledge of the matter told Reuters.<\/p>\n\n\n\n<p>\u201cIf something happens, a patient dies, we will not be able to question them (Pfizer). If somebody challenges in a court of law, the central government will be responsible for everything, not the company,\u201d the source added.<\/p>\n\n\n\n<p>Pfizer and the health ministry did not reply to Reuters requests for comment on Friday. The second source said Pfizer was not going to change its position on the indemnity issue. Both sources declined to be named as they were not authorised to talk to the media.<\/p>\n\n\n\n<p>India, which is facing a shortage of shots as coronavirus cases soar, pledged last month to fast-track approvals for overseas vaccine makers including Pfizer, Moderna and Johnson and Johnson.<\/p>\n\n\n\n<p>However, none have since sought permission from India\u2019s drug regulator to sell their vaccine, which has a population of 1.35 billion. The second source said that the other issue being discussed between Pfizer and New Delhi was the government\u2019s insistence on a local trial for any vaccine approval.<\/p>\n\n\n\n<p>Pfizer withdrew its application for emergency use authorisation for the vaccine developed with Germany\u2019s BioNTech in February after India insisted on such a trial.<\/p>\n\n\n\n<p>But three other shots on sale in India, developed by AstraZeneca, Russia\u2019s Sputnik V and Bharat Biotech in collaboration with state-run Indian Council of Medical Research, have completed the small-scale safety trials.<\/p>\n\n\n\n<p>Albert Bourla, Pfizer\u2019s chief executive said on May 4 that he was hopeful that the government would change its policy of local trials and that a path to delivering the drugmaker\u2019s shots in India could be found.<\/p>\n\n\n\n<p>A third source told Reuters that Foreign Minister S Jaishankar would visit the United States this month or in early June to try and address Pfizer\u2019s concerns and ease exports of vaccine raw materials to India.<\/p>\n\n\n\n<p>The foreign ministry did not immediately respond to a request for comment.<em>Source: https:\/\/www.ndtv.com\/india-news\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report-2446551<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>New Delhi\/New York:&nbsp;Pfizer and New Delhi are at loggerheads over [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":9783,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[87],"tags":[],"class_list":["post-9689","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-resources"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v18.8 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report - International Institute of Innovation and Technology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report\" \/>\n<meta property=\"og:description\" content=\"New Delhi\/New York:&nbsp;Pfizer and New Delhi are at loggerheads over [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/\" \/>\n<meta property=\"og:site_name\" content=\"International Institute of Innovation and Technology\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/International-Institute-of-Innovation-and-Technology-101979535699954\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-28T09:53:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-21T04:22:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/05\/mat-napo-kQrBavaF-Fk-unsplash-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@i3tkolkata\" \/>\n<meta name=\"twitter:site\" content=\"@i3tkolkata\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#\\\/schema\\\/person\\\/2ed104da3b2d63ba12c40da792d0bf2e\"},\"headline\":\"India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report\",\"datePublished\":\"2021-05-28T09:53:25+00:00\",\"dateModified\":\"2021-06-21T04:22:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/\"},\"wordCount\":440,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/mat-napo-kQrBavaF-Fk-unsplash-1.jpg\",\"articleSection\":[\"Resources\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/\",\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/\",\"name\":\"India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report - International Institute of Innovation and Technology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/mat-napo-kQrBavaF-Fk-unsplash-1.jpg\",\"datePublished\":\"2021-05-28T09:53:25+00:00\",\"dateModified\":\"2021-06-21T04:22:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/mat-napo-kQrBavaF-Fk-unsplash-1.jpg\",\"contentUrl\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/mat-napo-kQrBavaF-Fk-unsplash-1.jpg\",\"width\":640,\"height\":427},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/world-news\\\/resources\\\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#website\",\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/\",\"name\":\"International Institute of Innovation and Technology\",\"description\":\"Advancing New Frontiers in Research &amp; Education\",\"publisher\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#organization\",\"name\":\"International Institute of Innovation and Technology (I3TK)\",\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/i3tk-logo-v1.jpg\",\"contentUrl\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/i3tk-logo-v1.jpg\",\"width\":200,\"height\":200,\"caption\":\"International Institute of Innovation and Technology (I3TK)\"},\"image\":{\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/International-Institute-of-Innovation-and-Technology-101979535699954\",\"https:\\\/\\\/x.com\\\/i3tkolkata\",\"https:\\\/\\\/www.instagram.com\\\/i3tkolkata\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCOXcio6zwQO3YSQkwoZKNrQ\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/#\\\/schema\\\/person\\\/2ed104da3b2d63ba12c40da792d0bf2e\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/i3tk.org\\\/demo2\"],\"url\":\"https:\\\/\\\/i3tk.org\\\/demo2\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report - International Institute of Innovation and Technology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/","og_locale":"en_US","og_type":"article","og_title":"India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report","og_description":"New Delhi\/New York:&nbsp;Pfizer and New Delhi are at loggerheads over [&hellip;]","og_url":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/","og_site_name":"International Institute of Innovation and Technology","article_publisher":"https:\/\/www.facebook.com\/International-Institute-of-Innovation-and-Technology-101979535699954","article_published_time":"2021-05-28T09:53:25+00:00","article_modified_time":"2021-06-21T04:22:44+00:00","og_image":[{"width":640,"height":427,"url":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/05\/mat-napo-kQrBavaF-Fk-unsplash-1.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@i3tkolkata","twitter_site":"@i3tkolkata","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/#article","isPartOf":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/"},"author":{"name":"admin","@id":"https:\/\/i3tk.org\/demo2\/#\/schema\/person\/2ed104da3b2d63ba12c40da792d0bf2e"},"headline":"India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report","datePublished":"2021-05-28T09:53:25+00:00","dateModified":"2021-06-21T04:22:44+00:00","mainEntityOfPage":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/"},"wordCount":440,"commentCount":0,"publisher":{"@id":"https:\/\/i3tk.org\/demo2\/#organization"},"image":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/#primaryimage"},"thumbnailUrl":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/05\/mat-napo-kQrBavaF-Fk-unsplash-1.jpg","articleSection":["Resources"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/","url":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/","name":"India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report - International Institute of Innovation and Technology","isPartOf":{"@id":"https:\/\/i3tk.org\/demo2\/#website"},"primaryImageOfPage":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/#primaryimage"},"image":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/#primaryimage"},"thumbnailUrl":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/05\/mat-napo-kQrBavaF-Fk-unsplash-1.jpg","datePublished":"2021-05-28T09:53:25+00:00","dateModified":"2021-06-21T04:22:44+00:00","breadcrumb":{"@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/#primaryimage","url":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/05\/mat-napo-kQrBavaF-Fk-unsplash-1.jpg","contentUrl":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2021\/05\/mat-napo-kQrBavaF-Fk-unsplash-1.jpg","width":640,"height":427},{"@type":"BreadcrumbList","@id":"https:\/\/i3tk.org\/demo2\/world-news\/resources\/india-pfizer-at-impasse-over-vaccine-indemnity-demand-report\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/i3tk.org\/demo2\/"},{"@type":"ListItem","position":2,"name":"India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report"}]},{"@type":"WebSite","@id":"https:\/\/i3tk.org\/demo2\/#website","url":"https:\/\/i3tk.org\/demo2\/","name":"International Institute of Innovation and Technology","description":"Advancing New Frontiers in Research &amp; Education","publisher":{"@id":"https:\/\/i3tk.org\/demo2\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/i3tk.org\/demo2\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/i3tk.org\/demo2\/#organization","name":"International Institute of Innovation and Technology (I3TK)","url":"https:\/\/i3tk.org\/demo2\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/i3tk.org\/demo2\/#\/schema\/logo\/image\/","url":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2022\/01\/i3tk-logo-v1.jpg","contentUrl":"https:\/\/i3tk.org\/demo2\/wp-content\/uploads\/2022\/01\/i3tk-logo-v1.jpg","width":200,"height":200,"caption":"International Institute of Innovation and Technology (I3TK)"},"image":{"@id":"https:\/\/i3tk.org\/demo2\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/International-Institute-of-Innovation-and-Technology-101979535699954","https:\/\/x.com\/i3tkolkata","https:\/\/www.instagram.com\/i3tkolkata\/","https:\/\/www.youtube.com\/channel\/UCOXcio6zwQO3YSQkwoZKNrQ"]},{"@type":"Person","@id":"https:\/\/i3tk.org\/demo2\/#\/schema\/person\/2ed104da3b2d63ba12c40da792d0bf2e","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/52146bcbad3565e9d842646770b21e26751c22d5978bb87fce2c8fd80777bbda?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/i3tk.org\/demo2"],"url":"https:\/\/i3tk.org\/demo2\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/posts\/9689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/comments?post=9689"}],"version-history":[{"count":0,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/posts\/9689\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/media\/9783"}],"wp:attachment":[{"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/media?parent=9689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/categories?post=9689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i3tk.org\/demo2\/wp-json\/wp\/v2\/tags?post=9689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}